HOOKIPA Pharma

(OTC) HOOK

Current Price$1.18

Market Cap$14.61M

Since IPO (2019)-99%

5 Year-99%

1 Year-10%

1 Month+9%

HOOKIPA Pharma Financials at a Glance

Market Cap

$14.61M

Revenue (TTM)

$14.86M

Net Income (TTM)

$56.00M

EPS (TTM)

$-4.54

P/E Ratio

-0.26

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Price

$1.18

Volume

4,417

Open

$1.20

Price

$1.18

Volume

4,417

Open

$1.20

Previous Close

$1.19

Daily Range

$1.18 - $1.20

52-Week Range

$0.81 - $1.77

Dividend

$0.00

Beta (Volatility)

0.97 (Low)

Price

$1.18

Volume

4,417

Open

$1.20

Previous Close

$1.19

Daily Range

$1.18 - $1.20

52-Week Range

$0.81 - $1.77

HOOK News

2 Small-Cap Biotech Stocks to Watch in 2020

George Budwell, PhDJan 23, 2020

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About HOOKIPA Pharma

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Malte Peters, MD

Website

www.hookipapharma.com

Headquarters

New York City, NY 10118, US

HOOK Financials

Key Financial Metrics (TTM)

Gross Margin

100%

Operating Margin

-5%

Net Income Margin

-4%

Return on Equity

-98%

Return on Capital

-1%

Return on Assets

-80%

Earnings Yield

-3.85%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$14.61M

Shares Outstanding

12.33M

Volume

4.42K

Avg. Volume

11.62K

Financials (TTM)

Gross Profit

$9.02M

Operating Income

$36.57M

EBITDA

$35.89M

Operating Cash Flow

$11.50M

Capital Expenditure

$20.00K

Free Cash Flow

$11.52M

Cash & ST Invst.

$37.42M

Total Debt

$135.00K

HOOKIPA Pharma Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2025YOY CHG

Revenue

$6.79M

+426.7%

Gross Profit

$6.79M

+426.7%

Gross Margin

100.00%

N/A

Market Cap

$14.61M

N/A

Market Cap/Employee

$178.19K

N/A

Employees

N/A

Net Income

$1.79M

+90.6%

EBITDA

$1.32M

+92.8%

Quarterly Fundamentals

Name

Q2 2025YOY CHG

Net Cash

$33.68M

-53.4%

Accounts Receivable

$9.50M

-57.9%

Inventory

$0.00

N/A

Long Term Debt

$298.00K

-91.2%

Short Term Debt

$248.00K

-91.8%

Return on Assets

-80.00%

N/A

Return on Invested Capital

-1.16%

N/A

Free Cash Flow

$7.13M

+50.5%

Operating Cash Flow

$7.13M

+50.4%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

LVCLFAlgorae Pharmaceuticals Limited

LVCLFAlgorae Pharmaceuticals Limited$0.01+0.00%

LIANYLianBio

LIANYLianBio$0.12+0.00%

IMUCEOM Pharmaceuticals Holdings, Inc.

IMUCEOM Pharmaceuticals Holdings, Inc.$0.10+28.98%

NYMXFNymox Pharmaceutical Corporation

NYMXFNymox Pharmaceutical Corporation$0.07+8.65%

SRBCFSirona Biochem Corp.

SRBCFSirona Biochem Corp.$0.01+0.00%

PPCBPropanc Biopharma, Inc.

PPCBPropanc Biopharma, Inc.$0.10+0.19%

DVHGFDevonian Health Group Inc.

DVHGFDevonian Health Group Inc.$10.65+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

CNSPCns Pharmaceuticals

CNSPCns Pharmaceuticals$8.89+2.85%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$12.79-0.02%

PNSkycorp Solar Group

PNSkycorp Solar Group$5.27+0.84%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.86+0.03%

NCLHNorwegian Cruise Line

NCLHNorwegian Cruise Line$17.23-0.08%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$50.91+0.01%

ADTADT

ADTADT$7.02-0.07%

Questions About HOOK

What is the current price of HOOKIPA Pharma?

HOOKIPA Pharma is trading at $1.18 per share.

What is the 52-week range for HOOKIPA Pharma?

Over the past 52 weeks, HOOKIPA Pharma has traded between $0.81 and $1.77.

How much debt does HOOKIPA Pharma have?

As of the most recent reporting period, HOOKIPA Pharma reported total debt of $546,000.

How much cash does HOOKIPA Pharma have on hand?

HOOKIPA Pharma reported $34.34M in cash and cash equivalents in its most recent financial results.

What is HOOKIPA Pharma’s dividend yield?

HOOKIPA Pharma does not currently have a dividend yield.

HOOKIPA Pharma

HOOKIPA Pharma Financials at a Glance

HOOK News

2 Small-Cap Biotech Stocks to Watch in 2020

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About HOOKIPA Pharma

HOOK Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

HOOKIPA Pharma Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About HOOK

What is the current price of HOOKIPA Pharma?

What is the 52-week range for HOOKIPA Pharma?

How much debt does HOOKIPA Pharma have?

How much cash does HOOKIPA Pharma have on hand?

What is HOOKIPA Pharma’s dividend yield?

Premium Investing Services